ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 251 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q2 2018. The put-call ratio across all filers is 0.19 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $12,481,000 | +12.9% | 875,867 | -4.9% | 0.54% | +11.3% |
| Q2 2018 | $11,054,000 | -6.4% | 921,135 | -3.7% | 0.49% | -5.4% |
| Q1 2018 | $11,815,000 | -16.6% | 956,666 | -1.7% | 0.52% | -14.7% |
| Q4 2017 | $14,163,000 | -0.2% | 973,446 | -2.4% | 0.60% | -1.1% |
| Q3 2017 | $14,187,000 | +279.0% | 997,009 | +239.8% | 0.61% | +245.2% |
| Q2 2017 | $3,743,000 | – | 293,411 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GLENHILL ADVISORS LLC | 7,659,841 | $78,207,000 | 5.54% |
| Tamarack Advisers, LP | 765,000 | $7,811,000 | 5.52% |
| Rovida Advisors Inc. | 1,501,900 | $15,334,000 | 3.41% |
| Blue Harbour Group | 9,309,695 | $95,052,000 | 3.18% |
| Casdin Capital, LLC | 280,000 | $2,859,000 | 2.36% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 1,988,300 | $20,301,000 | 1.97% |
| Adirondack Research & Management Inc. | 555,661 | $5,673,000 | 1.93% |
| BROADVIEW ADVISORS LLC | 1,006,550 | $10,277,000 | 1.37% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 13,268,624 | $135,473,000 | 1.25% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 4,627,481 | $47,247,000 | 0.71% |